2 Results for "

2027476-29-3

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "2027476-29-3" in MCE Product Catalog:

Cat. No.: HY-P10941
CAS No.: 2027476-29-3
Target:  

Integrin FAK ERK

Research Areas:  

Inflammation/Immunology Cancer

VSLRGDTRG is a synthetic peptide containing the RGD motif from cadherin 17 (CDH17), which binds to α2β1 integrin and activates its signaling pathway. VSLRGDTRG promotes the high-affinity conformational change of β1 integrin through the RGD motif, enhancing cell adhesion and phosphorylation of FAK and ERK1/2, thereby driving tumor proliferation and metastasis. VSLRGDTRG can be used in research on cancers expressing CDH17, such as colon cancer and pancreatic cancer .
loading...
    loading...
Cat. No.: HY-P10941A
Target:  

Integrin FAK ERK

Research Areas:  

Inflammation/Immunology Cancer

VSLRGDTRG acetate is a synthetic peptide containing the RGD motif from cadherin 17 (CDH17), which binds to α2β1 integrin and activates its signaling pathway. VSLRGDTRG acetate promotes the high-affinity conformational change of β1 integrin through the RGD motif, enhancing cell adhesion and phosphorylation of FAK and ERK1/2, thereby driving tumor proliferation and metastasis. VSLRGDTRG acetate can be used in research on cancers expressing CDH17, such as colon cancer and pancreatic cancer .
loading...
    loading...